Classical and emergent measures for clinical trials in ALS.
Miller
Robert G
RG
San Francisco, CA, USA.
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D003362:Cost-Benefit Analysis; D023381:Endpoint Determination; D006801:Humans; D008279:Magnetic Resonance Imaging; D018482:Muscle, Skeletal / Q000503:physiopathology; D012107:Research Design; D013534:Survival